Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass

Coagulation; Intravascular Clinical Trial

Official title:
Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass: A Blinded Randomized Control Trial Comparing Two Strategies

Status Completed

Clinical Trial Summary

The purpose of this study is to compare two different dosing strategies of a drug named protamine.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Coagulation; Intravascular

Clinical Trial Details

NCT number	NCT05426031
Study type	Interventional
Source	University of Miami
Contact
Status	Completed
Phase	Phase 4
Start date	June 28, 2022
Completion date	June 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05033704` - Effect of Human Plasma Protein Transfusion With and Without Crystalloids During Major Liver Resection Surgeries	N/A
Completed	`NCT02475694` - Acute Lung Injury After Cardiac Surgery: Pathogenesis	N/A
Completed	`NCT03897621` - The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery	N/A
Terminated	`NCT01961804` - PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma	Phase 3
Completed	`NCT05059431` - The Effect of Human Prostate Tissue on Platelet Activation
Completed	`NCT01935557` - Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation	Phase 3
Completed	`NCT02663960` - Compare Efficacy and Simplicity of Regional Citrate Anticoagulation With Fixed Dose Versus Adjusted Citrate Program	Phase 4